
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Ridker, Paul M, MacFadyen, Jean G, Thuren, Tom, Everett, Brendan M, Libby, Peter, Glynn, Robert J, Ridker, Paul, Lorenzatti, Alberto, Krum, Henry, Varigos, John, Siostrzonek, Peter, Sinnaeve, Peter, FLangue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(17)32247-X
Date:
August, 2017
Fichier:
PDF, 348 KB
english, 2017